A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection
This study has been completed.
R W Johnson Pharmaceutical Research Institute
First Posted: August 31, 2001
Last Update Posted: March 17, 2014
Information provided by:
NIH AIDS Clinical Trials Information Service